Catalyst Wire Dossier Catalyst Wire Dossier

HTU-520

· Hisamitsu Pharmaceutical Co., Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HTU-520, covering 2015-06-04 to 2015-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail [Phase 2]

See pricing